Scinovex
reviewTop 1% cited

The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases

Trends in Pharmacological Sciences · 2003 · Vol. 24(9) · pp. 471–478
Hua CaiKathy K. GriendlingDavid G. Harrison
Nitric Oxide and Endothelin EffectsAdenosine and Purinergic SignalingRenin-Angiotensin System StudiesNAD+ kinaseNAD(P)H oxidaseNADPH oxidaseBiochemistryReactive oxygen speciesEnzymeOxidase testAngiogenesisInflammationVascular smooth muscle

MeSH terms

Angiotensin IIAnimalsBlood VesselsCardiovascular AgentsCardiovascular DiseasesEnzyme ActivationHumansReactive Oxygen SpeciesNADPH OxidasesMice
Citations
687
FWCI
30.27
field-weighted impact
References
85
Percentile
100%
vs. same field & year
Citations per year
Cited by
Myeloperoxidase and Cardiovascular Disease
Arteriosclerosis Thrombosis and Vascular Biology · 2005 · 781 citations
Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2005 · 480 citations
Physiology of Local Renin-Angiotensin Systems
Physiological Reviews · 2006 · 1,727 citations
Neurovascular regulation in the normal brain and in Alzheimer's disease
Nature reviews. Neuroscience · 2004 · 2,187 citations
Related articles
The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases
Trends in Pharmacological Sciences · 2003 · 687 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases · Scinovex